Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Y-27632 demonstrates beneficial effects on hepatic fat-storing cells and hepatic fibrosis

April 26, 2000

Worldwide licensing agreement announced for MKC-733

April 26, 2000

New agents for GI disorders patented by Byk Gulden

April 26, 2000

Zeria updates status of GI pipeline

April 25, 2000

ID Biomedical licenses oral E. coli vaccine technology

April 25, 2000

New controlled-release, microencapsulated HBV vaccine prepared in China

April 24, 2000

NIH research sheds light on chronic hepatitis C

April 24, 2000

Glaxo Wellcome obtains nonexclusive HCV license from Chiron

April 20, 2000

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

April 20, 2000

Dainippon describes motility-enhancing activity of 5-HT4 receptor agonists

April 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...